Calibre Post Acute: Drug Review Failures - NM
The resident, identified in inspection records as Resident 16, had been prescribed escitalopram and trazodone. Both medications carried the same warning: closely monitor all antidepressant-treated patients for clinical worsening and for emergence of suicidal thoughts and behaviors. His care plan contained none of that monitoring. No specific depression behaviors for staff to track. No instructions to watch for suicidal ideation. No non-pharmacological interventions for his depression diagnosis at all.
What the care plan did include was monitoring for inappropriate sexual behaviors toward female staff and female residents.
A licensed practical nurse confirmed during an interview with inspectors on October 10 that Resident 16 had not been monitored for suicidal thoughts, had not been monitored for depression symptoms, and had no non-pharmacological interventions in place for his depression. The director of nursing confirmed the same findings the same day, acknowledging that the care plan should have specified what behaviors staff were watching for and what interventions were in place to treat the depression.
The director of nursing confirmed it at 12:05 in the afternoon, in plain language: the care plan did not include any specific behaviors related to depression that staff should monitor for, did not include non-pharmacological interventions, and did not include instructions to watch for worsening depression or the emergence of suicidal thoughts or suicidal behaviors.
Federal inspectors tagged the deficiency under care planning requirements and rated the level of harm as minimal harm or potential for actual harm, affecting some residents. The inspection was conducted November 18, 2025, following a complaint.
A man on two medications that each warned of suicide risk went unmonitored for how he was feeling, whether he was getting worse, or whether he was thinking about ending his life.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Calibre Post Acute, LLC from 2025-11-18 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: Official federal inspection data from the Centers for Medicare & Medicaid Services (CMS).
Editorial process: AI-synthesized regulatory data, reviewed for accuracy by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: August 4, 2026 · Our methodology
Calibre Post Acute, LLC in Las Cruces, NM was cited for violations during a health inspection on November 18, 2025.
The resident, identified in inspection records as Resident 16, had been prescribed escitalopram and trazodone.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.